Physical Training and Cancer-a Multicenter Clinical Trial (Phys-Can)
Primary Purpose
Breast Cancer, Colorectal Cancer, Prostate Cancer
Status
Active
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
high intensity exercise
low/medium intensity exercise
Behavioral medicine strategies
Sponsored by
About this trial
This is an interventional treatment trial for Breast Cancer focused on measuring Breast cancer, prostate cancer, colorectal cancer, fatigue, physical exercise, randomised trial, intervention
Eligibility Criteria
Inclusion Criteria:
- understand and talk Swedish.
- patients with breast cancer who receive neoadjuvant / adjuvant chemotherapy and / or adjuvant radiotherapy and / or adjuvant endocrine treatment.
- patients with colorectal cancer who receive adjuvant chemotherapy.
- patients with prostate cancer who receive neoadjuvant / adjuvant endocrine treatment with the addition of curative radiation therapy.
Exclusion Criteria:
- Patients unable to perform basic activities of daily living.
- Patients with cognitive disorders such as dementia and severe psychiatric illness.
- Patients with disabilities that may prevent physical activity: (eg, unstable angina, heart failure, chronic obstructive pulmonary disease, orthopedic and neurological diseases).
- Breast cancer stage IIIb.
- Undergoing treatment for other types of malignant disease.
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Arm Type
Experimental
Experimental
Experimental
Experimental
Arm Label
High intensity
Low/Medium intensity
High Intensity with BM
Low/Medium intensity with BM
Arm Description
high intensity exercise 80-90%
low/medium intensity exercise 40-50%
high intensity exercise with Behavioral medicine strategies¨ 80-90%
low/medium intensity exercise with Behavioral medicine strategies 40-50%
Outcomes
Primary Outcome Measures
Change in Fatigue
Multi Dimensional Fatigue Inventory (MFI),
Secondary Outcome Measures
Change in Quality of Life
The European Organisation for Research and Treatment of Cancer (EORTC)EORTC-QLQ30
Change in Mood disturbance
Hospital Anxiety and Depression Scale- (HADs)
Change in Function in Daily life
WHO Disability Assessment Schedule
Change in pain
Brief Pain Inventory
Change in Cardio respiratory fitness
maximal oxygen uptake (VO2 max test)
Change in Muscle strength
One Repetition Maximum Lower extremities: One Repetition Maximum (leg press)
Health Economy
Euroqol- (EQ5D)
Cancer recurrence
number of patients with recurrence
Sleep
Insomnia severe index
Health Economy register
register data
Cancer recurrence
Medical records
Treatment completion rate
Medical records
Full Information
NCT ID
NCT02473003
First Posted
October 10, 2014
Last Updated
November 1, 2022
Sponsor
Uppsala University
Collaborators
The Swedish Research Council, Swedish Cancer Society, Nordic Cancer Union, Linkoeping University, Lund University, University of Agder, Copenhagen University Hospital, Denmark, Norwegian School of Sport Sciences, Amsterdam UMC, location VUmc, University of Amsterdam, University of Leeds
1. Study Identification
Unique Protocol Identification Number
NCT02473003
Brief Title
Physical Training and Cancer-a Multicenter Clinical Trial
Acronym
Phys-Can
Official Title
Physical Training and Cancer- Effects and Understanding of Mechanisms for Prevent and Minimizing Cancer Related Fatigue, Improve Quality of Life and Disease Outcome
Study Type
Interventional
2. Study Status
Record Verification Date
November 2022
Overall Recruitment Status
Active, not recruiting
Study Start Date
March 2015 (undefined)
Primary Completion Date
December 2022 (Anticipated)
Study Completion Date
December 2025 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Uppsala University
Collaborators
The Swedish Research Council, Swedish Cancer Society, Nordic Cancer Union, Linkoeping University, Lund University, University of Agder, Copenhagen University Hospital, Denmark, Norwegian School of Sport Sciences, Amsterdam UMC, location VUmc, University of Amsterdam, University of Leeds
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Excessive tiredness (fatigue) is a common problem in cancer patients and can affect quality of life negatively. There is limited knowledge about the physical mechanisms that cause fatigue, and there is no medical treatment. Physical activity can reduce the inconvenience, but the investigators need to learn more about the type and intensity of exercise that works the best as well as how to motivate patients to exercise. The overall aim, is to evaluate the efficacy and cost-effectiveness of individually tailored high (H) and low/medium (LM) intensity physical training, with or without behavioural medicine (BM) support strategies, during adjuvant oncological treatment on; Cancer Related Fatigue (CRF),Quality of Life (QoL), mood disturbance, adherence to the cancer treatment, adverse effects, disease outcome, return to a daily life after completed treatment and return to work. The investigators will also describe changes in inflammatory markers and cytokines related to physical training and gene expressions following training to investigate whether these serve as mediators for the effects of physical training on CRF and QoL. This will be evaluated in newly diagnosed breast, colorectal and prostate cancer patients during adjuvant therapy at three different centres in Sweden; Uppsala, Lund/Malmö and Linköping. A 2x2 factorial design will be used, 600 patients will be randomised to H, H+BM, LM or LM+BM. Patients will train two times per week during 6 months. This project will give; new knowledge about aspects for individuals to gain improved well-being and quality of life, facilitated return to work, and possibly reduced risk of cancer recurrence. This in turn would result in lower burden on the health care system, reduced societal costs and have a positive impact on public health. Implementation of the results into clinical practice will be facilitated by the close collaboration between researchers and clinicians, and the fact that the study is performed in clinical settings.
Detailed Description
Purpose and Aims The main aim is to determine the effects of high or low intensity physical training with or without integrated behavioral medicine support strategies to prevent and minimize cancer related fatigue (CRF), improve health related quality of life (QoL) and to understand the role of inflammation and cytokines in the development and maintenance of CRF, as well as to increase knowledge with respect to cost-effectiveness of rehabilitation programs. This will be evaluated in newly diagnosed breast, colorectal and prostate cancer patients during adjuvant therapy at three different centers in Sweden; Uppsala, Lund/Malmö and Linköping and one in Norway.
More specifically, the investigators' objectives are to:
Investigate the effects of high intensity training compared to low intensity training on patient reported outcomes (CRF as primary endpoint), chemotherapy/radiation completion rates, medical (oncology) adverse effects, physical activity and daily function, during adjuvant treatment and at long-term-follow up. In addition, effects on the course of disease (e.g time to relapse).
Investigate if supplemental behavioural medicine support strategies increase adherence to exercise during adjuvant therapy and further if they increase the maintenance of physical activity behaviours and decrease sedentary time in the long run.
Explore the role of changes in inflammatory markers and cytokines related to physical training and following training to investigate whether these serve as mediators for the effects of physical training on CRF and QoL.
Pursue the investigation of a direct role of cytokines secreted from the working muscles, in inhibiting cancer cell growth and inducing apoptosis.
Evaluate health economic issues; cost effectiveness of the interventions, health production and individual wellbeing.
In Phys-Can, the investigators will implement rigorously designed and adequately powered randomized longitudinal multicenter clinical trials, with physical training and behavioral medicine support interventions. The highly multi- and interdisciplinary and international consortium behind this proposal is in an excellent position to perform international and interdisciplinary competence- and network-building activities to generate valid, high quality data covering all areas included in the project, from basic biomedical data to patient reported outcomes (PROs), i.e. from bench to bedside. This is unique in health care sciences.
Study design A 2x2 factorial design will be used. With this design the investigators can study main effects and interactions between factors (groups). Patients will be randomized to one of the following groups; A) individually tailored high intensity training twice a week with (H+BM) or without behavioral medicine support strategies (H) or B) individually tailored low intensity training twice a week with (L+BM) or without behavioral medicine support strategies (L).
Study sample/procedure Patients, who are recently diagnosed with breast cancer, colorectal cancer or prostate cancer and scheduled for adjuvant therapy at Uppsala, Lund/Malmö, Linköping and Haukeland University hospitals will be consecutively included in the study. Based on the power calculation, 612 patients will be included.
All patients will exercise twice a week during 6 months which is equal to the most extensive adjuvant treatment period. It is also an optimal period to achieve physical training effects and to establish physical activity behavior. Physical training under the guidance of trained coaches will be offered twice a week. Training intensity is 40-50% (low intensity group) or 80-90% (high intensity group) of maximal cardiorespiratory fitness/muscular strength. Physical training sessions consist of both cardiorespiratory and resistance exercise. Every four week, progress from resistance training is evaluated by means of a strength test, and absolute intensity is adjusted accordingly Motivational and self-regulatory behavioral medicine support strategies (motivational and self-regulatory strategies) will be provided for the H+BM and the L+BM groups i.e. strategies to enhance engagement in the high and low intensity exercise programs respectively, and to maintain health enhancing physical activity after the completion of the programs.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Breast Cancer, Colorectal Cancer, Prostate Cancer
Keywords
Breast cancer, prostate cancer, colorectal cancer, fatigue, physical exercise, randomised trial, intervention
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
600 (Actual)
8. Arms, Groups, and Interventions
Arm Title
High intensity
Arm Type
Experimental
Arm Description
high intensity exercise 80-90%
Arm Title
Low/Medium intensity
Arm Type
Experimental
Arm Description
low/medium intensity exercise 40-50%
Arm Title
High Intensity with BM
Arm Type
Experimental
Arm Description
high intensity exercise with Behavioral medicine strategies¨ 80-90%
Arm Title
Low/Medium intensity with BM
Arm Type
Experimental
Arm Description
low/medium intensity exercise with Behavioral medicine strategies 40-50%
Intervention Type
Behavioral
Intervention Name(s)
high intensity exercise
Intervention Description
high intensity exercise 80-90%
Intervention Type
Behavioral
Intervention Name(s)
low/medium intensity exercise
Intervention Description
low/medium intensity exercise 40-50%
Intervention Type
Behavioral
Intervention Name(s)
Behavioral medicine strategies
Intervention Description
Motivational and self-regulatory behavioral medicine support strategies
Primary Outcome Measure Information:
Title
Change in Fatigue
Description
Multi Dimensional Fatigue Inventory (MFI),
Time Frame
post oncol treatment (expected time frame 6-8 weeks), 6 month, 1,2,5 years
Secondary Outcome Measure Information:
Title
Change in Quality of Life
Description
The European Organisation for Research and Treatment of Cancer (EORTC)EORTC-QLQ30
Time Frame
post oncol treatment (expected time frame 6-8 weeks), 6 month, 1,2,5 years
Title
Change in Mood disturbance
Description
Hospital Anxiety and Depression Scale- (HADs)
Time Frame
post oncol treatment (expected time frame 6-8 weeks), 6 month, 1,2,5 years
Title
Change in Function in Daily life
Description
WHO Disability Assessment Schedule
Time Frame
6 months,1, 2, 5 years
Title
Change in pain
Description
Brief Pain Inventory
Time Frame
post oncol treatment (expected time frame 6-8 weeks), 6 month, 1,2,5 years
Title
Change in Cardio respiratory fitness
Description
maximal oxygen uptake (VO2 max test)
Time Frame
6 month
Title
Change in Muscle strength
Description
One Repetition Maximum Lower extremities: One Repetition Maximum (leg press)
Time Frame
6 months
Title
Health Economy
Description
Euroqol- (EQ5D)
Time Frame
12 months
Title
Cancer recurrence
Description
number of patients with recurrence
Time Frame
10 year
Title
Sleep
Description
Insomnia severe index
Time Frame
6 months
Title
Health Economy register
Description
register data
Time Frame
12 months
Title
Cancer recurrence
Description
Medical records
Time Frame
6 months, 1, 2, 5, 10 years
Title
Treatment completion rate
Description
Medical records
Time Frame
1, 2, 5, 10 year
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
understand and talk Swedish.
patients with breast cancer who receive neoadjuvant / adjuvant chemotherapy and / or adjuvant radiotherapy and / or adjuvant endocrine treatment.
patients with colorectal cancer who receive adjuvant chemotherapy.
patients with prostate cancer who receive neoadjuvant / adjuvant endocrine treatment with the addition of curative radiation therapy.
Exclusion Criteria:
Patients unable to perform basic activities of daily living.
Patients with cognitive disorders such as dementia and severe psychiatric illness.
Patients with disabilities that may prevent physical activity: (eg, unstable angina, heart failure, chronic obstructive pulmonary disease, orthopedic and neurological diseases).
Breast cancer stage IIIb.
Undergoing treatment for other types of malignant disease.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Karin Nordin, Professor
Organizational Affiliation
Uppsala University
Official's Role
Principal Investigator
12. IPD Sharing Statement
Citations:
PubMed Identifier
36269530
Citation
Schauer T, Henriksson A, Strandberg E, Lindman H, Berntsen S, Demmelmaier I, Raastad T, Nordin K, Christensen JF. Pre-treatment levels of inflammatory markers and chemotherapy completion rates in patients with early-stage breast cancer. Int J Clin Oncol. 2023 Jan;28(1):89-98. doi: 10.1007/s10147-022-02255-0. Epub 2022 Oct 21.
Results Reference
derived
PubMed Identifier
35964124
Citation
Brooke HL, Mazzoni AS, Buffart LM, Berntsen S, Nordin K, Demmelmaier I. Patterns and determinants of adherence to resistance and endurance training during cancer treatment in the Phys-Can RCT. BMC Sports Sci Med Rehabil. 2022 Aug 13;14(1):155. doi: 10.1186/s13102-022-00548-5.
Results Reference
derived
PubMed Identifier
34823494
Citation
Mazzoni AS, Brooke HL, Berntsen S, Nordin K, Demmelmaier I. Effect of self-regulatory behaviour change techniques and predictors of physical activity maintenance in cancer survivors: a 12-month follow-up of the Phys-Can RCT. BMC Cancer. 2021 Nov 25;21(1):1272. doi: 10.1186/s12885-021-08996-x.
Results Reference
derived
PubMed Identifier
33608485
Citation
Schauer T, Mazzoni AS, Henriksson A, Demmelmaier I, Berntsen S, Raastad T, Nordin K, Pedersen BK, Christensen JF. Exercise intensity and markers of inflammation during and after (neo-) adjuvant cancer treatment. Endocr Relat Cancer. 2021 Mar;28(3):191-201. doi: 10.1530/ERC-20-0507.
Results Reference
derived
PubMed Identifier
32909467
Citation
Mazzoni AS, Brooke HL, Berntsen S, Nordin K, Demmelmaier I. Exercise Adherence and Effect of Self-Regulatory Behavior Change Techniques in Patients Undergoing Curative Cancer Treatment: Secondary Analysis from the Phys-Can Randomized Controlled Trial. Integr Cancer Ther. 2020 Jan-Dec;19:1534735420946834. doi: 10.1177/1534735420946834.
Results Reference
derived
PubMed Identifier
31703567
Citation
Johnsson A, Demmelmaier I, Sjovall K, Wagner P, Olsson H, Tornberg AB. A single exercise session improves side-effects of chemotherapy in women with breast cancer: an observational study. BMC Cancer. 2019 Nov 8;19(1):1073. doi: 10.1186/s12885-019-6310-0.
Results Reference
derived
PubMed Identifier
28347291
Citation
Berntsen S, Aaronson NK, Buffart L, Borjeson S, Demmelmaier I, Hellbom M, Hojman P, Igelstrom H, Johansson B, Pingel R, Raastad T, Velikova G, Asenlof P, Nordin K. Design of a randomized controlled trial of physical training and cancer (Phys-Can) - the impact of exercise intensity on cancer related fatigue, quality of life and disease outcome. BMC Cancer. 2017 Mar 27;17(1):218. doi: 10.1186/s12885-017-3197-5.
Results Reference
derived
Learn more about this trial
Physical Training and Cancer-a Multicenter Clinical Trial
We'll reach out to this number within 24 hrs